The Wire: Prejudice against Dalits
UC expert on Dalit culture: How prejudice can travel from India to the U.S.
In an article in The Wire adressing discrimination allegations against Cisco, Shailaja Paik, a University of Cincinnati associate professor in the Department of History, likens the modern-day expression of the centuries-old Indian caste system to the mutation of a virus. At a time when the world is reeling from the coronavirus pandemic, she says feels the caste system is an even more dangerous malaise — “a shape-shifting virus than travels across continents and mutates over time.”
Paik, who has extensively researched the oppression of Dalits, talks of the transnationalisation of caste, as Indians carry the baggage of caste across oceans, with dominant oppressor castes trying to recreate structures of power and privilege.
>Read a profile of Dr. Paik and her journey from the slums of India to academia
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.